Solid Cancer Genomic testing

Solid cancer clinical indications are included in both the Rare Disease and Cancer National Genomics Test Directories as follows:

Solid cancer clinical indications

NHSE National Genomics Test Directory	Clinical Indication Category	Link for further details
Rare Disease	Inherited Cancer (22 clinical indications)	More details on rare disease testing
	Endocrinology (4 clinical indications)
	Neurology (3 clinical indications)
Cancer	Adult Solid Tumours (29 clinical indications)	More details on adult solid tumours
	Neurological (31 clinical indications)	More details on neurological tumours
	Paediatric (46 clinical indications) Also eligible for WGS	More details on paediatric tumours More details on whole genome sequencing
	Sarcoma (54 clinical indications) Also eligible for WGS	More details on sarcoma More details on whole genome sequencing

WMRGL provides both germline and somatic genetic testing as appropriate according to current NHSE eligibility criteria [1] and [2].

Please refer to the relevant Clinical Indication Category link for details of which local, regional and national testing services are provided by WMRGL.

References

National Genomic Test Directories